Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Net Debt Issuances and Repayments: 2022-2023

  • Universe Pharmaceuticals' Net Debt Issuances and Repayments rose 66.67% to $166,666.7 billion in Q1 2023 from the same period last year, while for Mar 2023 it was $166,666.7 billion, marking a year-over-year increase of 66.67%. This contributed to the annual value of $166,666.7 billion for FY2022, which is N/A change from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Net Debt Issuances and Repayments of $166,666.7 billion as of Q1 2023, which was down 0.00% from $166,666.7 billion recorded in Q3 2022.
  • Universe Pharmaceuticals' 5-year Net Debt Issuances and Repayments high stood at $166,666.7 billion for Q3 2022, and its period low was $100,000.0 billion during Q1 2022.
  • Moreover, its 2-year median value for Net Debt Issuances and Repayments was $166,666.7 billion (2023), whereas its average is $144,444.4 billion.
  • Data for Universe Pharmaceuticals' Net Debt Issuances and Repayments shows a peak YoY spiked of 66.67% (in 2023) over the last 5 years.
  • Over the past 2 years, Universe Pharmaceuticals' Net Debt Issuances and Repayments (Quarterly) stood at $166,666.7 billion in 2022, then surged by 66.67% to $166,666.7 billion in 2023.
  • Its Net Debt Issuances and Repayments was $166,666.7 billion in Q1 2023, compared to $166,666.7 billion in Q3 2022 and $100,000.0 billion in Q1 2022.